Skip to content

NanoU
Contact Us
Careers

nanostring logo

Products
Research Focus
- Drug Development and Biomarker Discovery
  
  Learn how our spatial ecosystem can accelerate the process.
- BioPharma
- Spatial Multiomics
- Oncology
- Cell & Gene Therapy Solutions
- Spatial Transcriptomics
- Agriculture, VetMed, and Model Organisms
- Gene Expression Profiling Signatures
- Immunology
- Infectious Disease
- Neuroscience
Support & Resources
- NanoString University
  
  Your source for NanoString product manuals, videos, tips and more.
- Product Support
- Researcher Tools
- Events & Webinars
- Publications & Media
- Customer Experience Labs
  - Seattle CX Lab
  - Amsterdam CX Lab
Company
- Join Our Team
  
  Advance your career and contribute to the development of new technologies.
- About Us
- News Center
- Careers
  - Careers at NanoString
  - Current Openings
- Partners & Providers
- Social Responsibility
- Investor Information
- Contact Us

Search Terms

NanoString.com

NanoString University

Academic Publications

Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna® Test in the management of early-stage breast cancers.

This website includes information regarding worldwide products and services, not all of which are available in every country.

Catalyzing the next biological revolution to improve the human condition.

© 2024 NanoString Technologies, Inc. All rights reserved.

Privacy Policy
Cookies Policy
Website Terms Of Use

Quick Links

Products
Research Focus
Resources
About Us
Investors
Publications
Events
Blog
Careers
Legal
Site Map

Connect

530 Fairview Ave N, Seattle, WA 98109
1-888-358-6266

Contact Us

Facebook
LinkedIn
Twitter
YouTube
Instagram

We use cookies to improve our website, for analytics, and for marketing purposes. By clicking “Agree” or by continuing to browse this site, you agree to our use of cookies and the corresponding data processing. For more information, please review our privacy policy and cookie policy.